Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ECCO 15 - ESMO 34 /
A new era of melanoma treatment

20th - 24th Sep 2009

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 24.09.09
Views: 17376

Prof Alexander Eggermont - President of the European CanCer Organisation

Prof Alexander Eggermont, President of the European CanCer Organisation, talks to Editor Gordon McVie about a new era of melanoma treatment, immunomodulation, combination immunotherapy, ipilimumab's unprecedented success in increasing the 2 year survival rate, the EORTC 18071 trial, BRAF mutations, ECCO's lifetime achievement award and his initiative of 'oncopolicy'.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation